The filing is a routine insider sale by a venture capital fund that has been gradually reducing its position. Monitor for any acceleration of selling by Crosslink affiliates in future Form 4 filings, but this single notice is not actionable.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 16 $34.29entry
- T+1 · 12h ago −3.85%α −2.83% · $32.97
- T+5 · in 6d Pending
- T+20 · in 28d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Crosslink Crossover Fund VI, L.P., a director and early investor in Chime Financial, filed a Form 144 notice of intent to sell 64,000 shares of common stock, with an approximate market value of $2.15 million based on the filing date. The filing is part of a broader pattern of recent sales by Crosslink affiliates, including Crosslink Crossover Fund VII and Crosslink Ventures VII, which have sold over 1 million shares in September 2026. The proposed sale is small relative to Chime's $12.7 billion market cap and does not indicate a change in the company's fundamentals.
Key Facts
- Crosslink Crossover Fund VI, L.P., a director and early investor, filed Form 144 to sell 64,000 shares of Chime Financial common stock.
- The proposed sale has an approximate market value of $2,146,156.80 based on the filing date.
- The shares were originally acquired from the issuer on October 27, 2014 in a private transaction.
- Crosslink affiliates (Fund VI, Fund VII, and Ventures VII) have sold over 1 million shares in multiple transactions during September 2026.
- The sale is small relative to Chime's $12.7 billion market cap (0.017% dilution).
Financial Impact
Proposed sale of 64,000 shares valued at approximately $2.15 million, representing less than 0.02% of Chime's market cap.
Risk Factors
- Form 144 is an intent to sell; the sale may not be executed.
- Insider selling by a director could signal reduced confidence, but the amount is small and part of a gradual distribution pattern.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-011090 |
| Document: 0001950047-26-011090-index.html | 0001950047-26-011090 |
| Document: 0001950047-26-011090.txt | 0001950047-26-011090 |
Track record
39 reports on CHYM
9 of 14 bullish or bearish reports moved the stock their way by T+5. Best: +14.85% at T+5 after the Sep 14, 2026 report. 12 of 14 went positive at some point.
Filters
- Nov 17, 2026today Insider Cluster Neutral 3/10 Entry price pending
- Nov 17, 2026today 144 Neutral 2/10 Entry $32.97 Now $32.97 +0.00% settles Nov 25
- Nov 17, 2026today 144 Neutral 3/10 Entry $32.98 Now $32.97 −0.03% settles Nov 25
- Nov 17, 2026today 144 Neutral 2/10 Entry $32.97 Now $32.97 +0.00% settles Nov 25
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $34.29 Now $32.97 −3.85% settles Nov 24
- Nov 16, 20261d ago 144 Neutral 3/10 Entry $34.36 Now $32.97 −4.05% settles Nov 24
- Nov 16, 20261d ago 144 Neutral 2/10 Entry $34.36 Now $32.97 −4.05% settles Nov 24
- Nov 13, 20264d ago SC 13G/A Neutral 3/10 Entry $34.29 Now $32.97 −3.85% settles Nov 23
- Nov 13, 20264d ago 144 Neutral 2/10 Entry $34.29 Now $32.97 −3.85% settles Nov 23
- Nov 13, 20264d ago 144 Neutral 2/10 Viewing Entry $34.29 Now $32.97 −3.85% settles Nov 23
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers